TPTX(Delisted)
Turning Point Therapeutics·NASDAQ
--
--(--)
TPTX fundamentals
During Q2 2022, Turning Point Therapeutics (TPTX) reported revenue of 119.00K, a YoY change of -97.70%. Net income was -123.09M, a YoY change of -118.73%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | TTM |
|---|
Start Date | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | -- |
End Date | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 25.00M -- | 0 -- | 25.20M -- | 5.16M -- | 460.00K -98.16% | 0 -- | 429.00K -98.30% | 119.00K -97.70% | 1.01M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 25.00M -- | 0 -- | 25.20M -- | 5.16M -- | 460.00K -98.16% | 0 -- | 429.00K -98.30% | 119.00K -97.70% | 1.01M -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 25.00M -- | 0 -- | 25.20M -- | 5.16M -- | 460.00K -98.16% | 0 -- | 429.00K -98.30% | 119.00K -97.70% | 1.01M -- |
Operating Expenses | 4.86M -- | 5.17M -- | 6.13M -- | 9.48M -- | 14.06M +189.40% | 18.45M +256.81% | 22.14M +261.23% | 23.07M +143.30% | 62.63M +345.26% | 32.73M +77.37% | 43.54M +96.65% | 47.94M +107.84% | 61.25M -2.19% | 61.82M +88.87% | 67.11M +54.14% | 78.64M +64.04% | 75.36M +23.04% | 124.48M +101.36% | 345.60M -- |
Selling, General and Administrative Expenses | 516.00K -- | 803.00K -- | 1.00M -- | 2.26M -- | 3.61M +600.39% | 4.74M +490.66% | 5.50M +450.00% | 5.92M +162.24% | 39.86M +1002.85% | 8.58M +80.86% | 11.33M +105.93% | 13.66M +130.65% | 19.99M -49.84% | 17.17M +100.17% | 18.22M +60.90% | 20.46M +49.77% | 20.31M +1.62% | 37.70M +119.53% | 96.70M -- |
Research and Development Expenses | 4.34M -- | 4.37M -- | 5.13M -- | 7.22M -- | 10.45M +140.58% | 13.71M +213.82% | 16.64M +224.43% | 17.14M +137.38% | 22.77M +117.86% | 24.15M +76.17% | 32.21M +93.59% | 34.27M +99.96% | 41.26M +81.22% | 44.65M +84.86% | 48.89M +51.77% | 58.18M +69.74% | 55.05M +33.41% | 86.79M +94.37% | 248.90M -- |
Operating Income | -4.86M -- | -5.17M -- | -6.13M -- | -9.48M -- | -14.06M -189.40% | -18.45M -256.81% | -22.14M -261.23% | -23.07M -143.30% | -62.63M -345.26% | -32.73M -77.37% | -18.54M +16.26% | -47.94M -107.84% | -36.05M +42.44% | -56.66M -73.09% | -66.65M -259.53% | -78.64M -64.04% | -74.94M -107.87% | -124.36M -119.50% | -344.59M -- |
Non-Operating Income (Loss) | 127.00K -- | 135.00K -- | 132.00K -- | 462.00K -- | 518.00K +307.87% | 1.31M +871.85% | 1.66M +1155.30% | 2.11M +355.84% | 1.91M +268.34% | 1.24M -5.56% | 834.00K -49.67% | 563.00K -73.27% | 545.00K -71.44% | 384.00K -69.01% | 328.00K -60.67% | 192.00K -65.90% | 490.00K -10.09% | 1.28M +232.29% | 2.29M -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | 855.00K -- | 518.00K -- | 1.31M -- | 1.66M -- | 2.11M +146.32% | 1.91M +268.34% | 1.24M -5.56% | 834.00K -49.67% | 563.00K -73.27% | 545.00K -71.44% | 384.00K -69.01% | 328.00K -60.67% | 192.00K -65.90% | 490.00K -10.09% | 1.28M +232.29% | 2.29M -- |
Net Interest Expense | -127.00K -- | -135.00K -- | -132.00K -- | 393.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | 127.00K -- | 135.00K -- | 132.00K -- | -393.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -4.73M -- | -5.04M -- | -6.00M -- | -9.02M -- | -13.55M -186.22% | -17.14M -240.32% | -20.48M -241.55% | -20.96M -132.41% | -60.72M -348.20% | -31.49M -83.72% | -17.70M +13.56% | -47.38M -126.04% | -35.50M +41.53% | -56.27M -78.68% | -66.33M -274.61% | -78.45M -65.59% | -74.44M -109.68% | -123.09M -118.73% | -342.31M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- |
Net Income | -4.73M -- | -5.04M -- | -6.00M -- | -9.02M -- | -13.55M -186.22% | -17.14M -240.32% | -20.48M -241.55% | -20.96M -132.41% | -60.72M -348.20% | -31.49M -83.72% | -17.70M +13.56% | -47.38M -126.04% | -35.50M +41.53% | -56.27M -78.68% | -66.33M -274.61% | -78.45M -65.59% | -74.44M -109.68% | -123.09M -118.73% | -342.31M -- |
Net Income Attributable to Owners of the Company | -4.73M -- | -5.04M -- | -6.00M -- | -9.02M -- | -13.55M -186.22% | -17.14M -240.32% | -20.48M -241.55% | -20.96M -132.41% | -60.72M -348.20% | -31.49M -83.72% | -17.70M +13.56% | -47.38M -126.04% | -35.50M +41.53% | -56.27M -78.68% | -66.33M -274.61% | -78.45M -65.59% | -74.44M -109.68% | -123.09M -118.73% | -342.31M -- |
Net Income Attributable to Common Stockholders | -4.73M -- | -5.04M -- | -6.00M -- | -9.02M -- | -13.55M -186.22% | -17.14M -240.32% | -20.48M -241.55% | -20.96M -132.41% | -60.72M -348.20% | -31.49M -83.72% | -17.70M +13.56% | -47.38M -126.04% | -35.50M +41.53% | -56.27M -78.68% | -66.33M -274.61% | -78.45M -65.59% | -74.44M -109.68% | -123.09M -118.73% | -342.31M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | 345.00K -- | -24.00K -- | -51.00K -- | -316.00K -- | 1.06M +208.12% | -606.00K -2425.00% | -203.00K -298.04% | -186.00K +41.14% | -22.00K -102.07% | -18.00K +97.03% | -1.26M -519.70% | -4.12M -2113.98% | -1.52M -6818.18% | -6.92M -- |
Total Comprehensive Income | -4.73M -- | -5.04M -- | -6.00M -- | -9.02M -- | -13.55M -186.22% | -16.80M -233.47% | -20.51M -241.95% | -21.01M -132.98% | -61.03M -350.54% | -30.43M -81.16% | -18.31M +10.71% | -47.58M -126.46% | -35.69M +41.52% | -56.30M -85.00% | -66.34M -262.31% | -79.71M -67.53% | -78.56M -120.13% | -124.61M -121.35% | -349.22M -- |
Total Comprehensive Income Attributable to Owners of the Company | -4.73M -- | -5.04M -- | -6.00M -- | -9.02M -- | -13.55M -186.22% | -16.80M -233.47% | -20.51M -241.95% | -21.01M -132.98% | -61.03M -350.54% | -30.43M -81.16% | -18.31M +10.71% | -47.58M -126.46% | -35.69M +41.52% | -56.30M -85.00% | -66.34M -262.31% | -79.71M -67.53% | -78.56M -120.13% | -124.61M -121.35% | -349.22M -- |
Basic EPS | -1.41 -- | -1.49 -- | -1.77 -- | -- -- | -3.96 -180.85% | -0.7 +53.02% | -0.63 +64.41% | -0.58 -- | -1.69 +57.32% | -0.82 -17.14% | -0.42 +33.33% | -0.97 -67.24% | -0.73 +56.80% | -1.14 -39.02% | -1.34 -219.05% | -1.58 -62.89% | -1.5 -105.48% | -2.48 -117.54% | -6.9 -- |
Diluted EPS | -1.41 -- | -1.49 -- | -1.77 -- | -- -- | -3.97 -181.56% | -0.7 +53.02% | -0.63 +64.41% | -- -- | -1.69 +57.43% | -0.82 -17.14% | -0.42 +33.33% | -- -- | -0.73 +56.80% | -1.14 -39.02% | -1.34 -219.05% | -- -- | -1.5 -105.48% | -2.48 -117.54% | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
